Cheat sheet

OPRA Exam Cheat Sheet

Practice this exam

Biomedical Sciences

  • 20% of exam
  • Physiology & Pathophysiology Microbiology & Immunology Electrolytes Disease States

Medicinal Chemistry & Biopharmaceutics

  • 10% of exam
  • Formulation & Drug Delivery Drug Stability Solubility Pharmaceutical Microbiology

Pharmacokinetics & Pharmacodynamics

  • 10% of exam
  • ADME Half-Life & Clearance Receptor Theory Dose-Response

Pharmacology & Toxicology

  • 15% of exam
  • Adverse Drug Reactions Drug Interactions Antidotes Mechanism of Action

Therapeutics & Patient Care

  • 45% of exam
  • PBS & Dispensing Medicine Scheduling Counselling & Safety Law & Ethics Special Populations

Quick Facts

  • Exam OPRA
  • Body APC / Pearson VUE
  • Questions 120 (90% scored)
  • Time 150 min
  • Result Pass / Unsuccessful
  • Fee AU$2,245 (2026)
  • Format Closed-book, CBT
  • Blueprint March 2025 launch

Physiology & Pathophysiology BI

  • Homeostasis Stable internal balance
  • Negative feedback Reverses change, restores balance
  • Sepsis criteria qSOFA or SIRS markers
  • Acid-base balance pH, CO2, bicarbonate control
  • Electrolyte imbalance Na, K, Ca disturbance
  • Inflammation markers CRP, ESR, WCC

Microbiology & Immunology BI

  • Gram stain Positive purple, negative pink
  • Innate immunity Fast, non-specific defence
  • Adaptive immunity Specific, memory-based response
  • Antibiotic resistance Beta-lactamase, efflux, target change
  • Vaccine types Live, inactivated, subunit, mRNA

Formulation & Drug Delivery ME

  • Bioavailability Fraction reaching systemic circulation
  • First-pass metabolism Liver reduces oral bioavailability
  • Enteric coating Delays release until intestine
  • Sustained release Slow, prolonged drug release
  • Solubility factors pH, particle size, temperature
  • Drug stability Resists degradation over time

Pharmaceutical Microbiology & QC ME

  • Sterility testing Confirms no microbial contamination
  • Preservatives Prevent microbial growth
  • Aseptic technique Prevents contamination during compounding
  • Endotoxin limit Pyrogen safety threshold

ADME Order PK

  • Absorption, Distribution, Metabolism, Excretion — in sequence
  • A: gut/site uptake D: spreads through tissues M: liver transforms drug E: kidney/bile removes drug

Zero-Order vs First-Order Kinetics PK

Zero-order kinetics

  • Constant amount eliminated
  • Rate independent of concentration

First-order kinetics

  • Constant fraction eliminated
  • Rate depends on concentration
  • Fixed amount vs fixed fraction

Pharmacokinetics Core PK

  • ADME Absorption, distribution, metabolism, excretion
  • Half-life Time to halve concentration
  • Volume of distribution Apparent body drug spread
  • Clearance Volume cleared per time
  • Steady state ~5 half-lives to reach
  • Loading dose Fast target concentration achieved
  • Zero-order kinetics Constant amount eliminated
  • First-order kinetics Constant fraction eliminated

Agonist vs Antagonist PK

Agonist

  • Binds, activates receptor
  • Produces a response

Antagonist

  • Binds, blocks receptor
  • No response produced
  • Turns on vs turns off

Pharmacodynamics Core PK

  • Agonist Activates receptor response
  • Antagonist Blocks receptor response
  • Therapeutic index Toxic dose over effective dose
  • ED50 Effective dose in 50%
  • Tolerance Reduced response, repeated exposure
  • Dose-response curve Effect size versus dose

Type A vs Type B ADR PH

Type A ADR

  • Dose-related, predictable
  • Common, extension of effect

Type B ADR

  • Not dose-related
  • Rare, idiosyncratic or allergic
  • Predictable vs unpredictable reaction

Antidote Picker PH

  • Paracetamol overdose → N-acetylcysteine
  • Opioid overdose/respiratory depression → Naloxone
  • Benzodiazepine overdose → Flumazenil ( Rarely used, seizure risk )
  • Warfarin overdose/bleeding → Vitamin K
  • Iron overdose → Desferrioxamine
  • Organophosphate/nerve agent exposure → Atropine

ADRs & Drug Interactions PH

  • Type A ADR Predictable, dose-related reaction
  • Type B ADR Unpredictable, idiosyncratic reaction
  • CYP450 inhibitor Raises interacting drug levels
  • CYP450 inducer Lowers interacting drug levels
  • Serotonin syndrome SSRI + MAOI risk
  • QT prolongation Risk of torsades de pointes

Toxicology & Antidotes PH

  • Paracetamol overdose Antidote: N-acetylcysteine
  • Opioid overdose Antidote: naloxone
  • Benzodiazepine overdose Antidote: flumazenil
  • Warfarin overdose Antidote: vitamin K
  • Iron overdose Antidote: desferrioxamine
  • Organophosphate poisoning Antidote: atropine

Scheduling Ladder TH

  • S2 to S8: control increases with each schedule
  • S2: pharmacy self-select S3: pharmacist supply only S4: prescription required S8: controlled, high risk

S3 vs S4 Scheduling TH

S3 Pharmacist Only

  • No script needed
  • Pharmacist supply + advice

S4 Prescription Only

  • Script required
  • Prescriber authorises use
  • Pharmacist supply vs prescriber required

Medicine Scheduling Picker TH

  • Self-selected, pharmacist advice available → S2 Pharmacy Medicine
  • Needs pharmacist supply, no script → S3 Pharmacist Only
  • Needs doctor's prescription → S4 Prescription Only
  • High addiction/abuse potential → S8 Controlled Drug
  • Banned from general sale → S9 Prohibited Substance
  • Uncertain schedule → Check current SUSMP

PBS & Dispensing TH

  • PBS Subsidises listed prescription medicines
  • General co-payment Up to AU$25 (2026)
  • Concessional co-payment AU$7.70 per script (2026)
  • Safety Net threshold AU$1,748.20 general (2026)
  • Concessional Safety Net AU$277.20 threshold (2026)
  • Authority prescription Needs PBS approval first
  • Repeats Authorised refills without new script

PBS Safety Net Order TH

  • Co-payment first, then Safety Net threshold, then reduced cost
  • Pay co-payment each script Reach annual threshold amount Concession: free after threshold General: cheaper after threshold

OPRA vs KAPS TH

OPRA (current, 2025+)

  • 120 MCQs, 150 minutes
  • Clinical judgement emphasis
  • Therapeutics weighted 45%

KAPS (retired 2024)

  • Legacy knowledge-only exam
  • Less patient-care weighting
  • OPRA current; KAPS retired

PBS Supply Picker TH

  • Concession card holder → Concessional co-payment applies
  • General patient, no card → General co-payment applies
  • Restricted PBS indication → Authority prescription required
  • Repeat needed, script allows → Dispense authorised repeat
  • Patient nears Safety Net → Track cumulative PBS spend
  • Non-PBS item requested → Private/full price script

Scheduling: SUSMP & Poisons Standard TH

  • S2 Pharmacy Medicine, self-selection
  • S3 Pharmacist Only, no script
  • S4 Prescription Only Medicine
  • S8 Controlled Drug, addiction risk
  • S9 Prohibited substance
  • SUSMP TGA Poisons Standard document

Five Competency Domains TH

  • Professionalism, Communication, Medicines, Leadership, Education — five domains
  • D1: professionalism and ethics D2: communication and collaboration D3: medicines management, patient care D4: leadership and management D5: education and research

AHPRA vs Pharmacy Board TH

AHPRA

  • National registration body
  • Handles notifications, all professions

Pharmacy Board of Australia

  • Sets pharmacist practice standards
  • Profession-specific decisions
  • Registers everyone vs sets standards

Law, Ethics & Regulators TH

  • AHPRA National registration + notifications body
  • Pharmacy Board of Australia Sets pharmacist practice standards
  • National Law Health practitioner regulation legislation
  • Mandatory notification Reports impairment, misconduct, risk
  • Code of conduct Professional behaviour expectations
  • Provisional registration Intern pharmacist pathway status

General vs Concessional Co-payment TH

General co-payment

  • Up to AU$25
  • No concession card

Concessional co-payment

  • Fixed AU$7.70
  • Concession card required
  • Card status sets the fee

Counselling & Patient Safety TH

  • CMI Consumer Medicine Information leaflet
  • MedsCheck Community pharmacy medicine review
  • HMR Home Medicines Review, GP-referred
  • DAA/Webster pack Dose administration aid
  • Health literacy Ability to understand health information
  • Adherence Following agreed treatment plan

Special Populations & Harm Minimisation TH

  • Pregnancy categories A to X risk scale
  • Renal dose adjustment Based on eGFR/CrCl
  • Paediatric dosing Weight-based, mg/kg calculation
  • Opioid substitution therapy Methadone or buprenorphine treatment
  • Needle and syringe program Reduces blood-borne virus spread
  • Elderly high-risk medicines Anticholinergics, sedatives, falls risk

Common Traps

OPRA ≠ KAPS

  • OPRA is current 2025+ exam ≠ KAPS retired November 2024

S3 ≠ S4 scheduling

  • S3 needs no script ≠ S4 needs a prescription

AHPRA ≠ Pharmacy Board

  • AHPRA runs registration admin ≠ Board sets practice standards

General ≠ concessional co-payment

  • General up to AU$25 ≠ Concession fixed at AU$7.70

Scored ≠ unscored questions

  • 90% of items scored ≠ 10% unscored, uncounted trial

Zero-order ≠ first-order kinetics

  • Zero-order: fixed amount removed ≠ First-order: fixed fraction removed

Type A ≠ Type B ADR

  • Type A dose-related, predictable ≠ Type B idiosyncratic, unpredictable

Last Minute

  • 1. 120 MCQs, 150 minutes total
  • 2. 90% scored, 10% unscored trial
  • 3. Therapeutics and patient care: 45%
  • 4. Biomedical sciences weighted at 20%
  • 5. Pharm/tox weighted at 15%
  • 6. PK/PD and chemistry each 10%
  • 7. Result is pass or unsuccessful
  • 8. No published fixed pass mark
  • 9. S3 no script, S4 needs script
  • 10. AHPRA registers; Board sets standards
  • 11. General co-pay ~AU$25, concession AU$7.70
  • 12. OPRA replaced KAPS, March 2025

Overseas Pharmacist Readiness Assessment (OPRA)

  • Practice Questions 142 questions Study Guide 35 topics Cheat Sheet 78 facts Flashcards 50 cards Podcast